An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene Interactions on risk of myocardial infarction: The importance of model validation
Authors:
- Christopher S CoffeyCCChristopher S Coffey
- Patricia R HebertPHPatricia R Hebert
- Marylyn D RitchieMRMarylyn D Ritchie
- Harlan M KrumholzHKHarlan M Krumholz
- J Michael GazianoJGJ Michael Gaziano
- Paul M RidkerPRPaul M Ridker
- Nancy J BrownNBNancy J Brown
- Douglas E VaughanDVDouglas E Vaughan
- Jason H MooreJMJason H Moore
Open Access
- 30 April 2004
- journal article
- research article
- Published by Springer Nature in BMC Bioinformatics
- Vol. 5 (1) , 49
Abstract
To examine interactions among the angiotensin converting enzyme (ACE) insertion/deletion, plasminogen activator inhibitor-1 (PAI-1) 4G/5G, and tissue plasminogen activator (t-PA) insertion/deletion gene polymorphisms on risk of myocardial infarction using data from 343 matched case-control pairs from the Physicians Health Study. We examined the data using both conditional logistic regression and the multifactor dimensionality reduction (MDR) method. One advantage of the MDR method is that it provides an internal prediction error for validation. We summarize our use of this internal prediction error for model validation. The overall results for the two methods were consistent, with both suggesting an interaction between the ACE I/D and PAI-1 4G/5G polymorphisms. However, using ten-fold cross validation, the 46% prediction error for the final MDR model was not significantly lower than that expected by chance. The significant interaction initially observed does not validate and may represent a type I error. As data-driven analytic methods continue to be developed and used to examine complex genetic interactions, it will become increasingly important to stress model validation in order to ensure that significant effects represent true relationships rather than chance findings.Keywords
This publication has 31 references indexed in Scilit:
- Power of multifactor dimensionality reduction for detecting gene‐gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneityGenetic Epidemiology, 2003
- A comparison of combinatorial partitioning and linear regression for the detection of epistatic effects of theACE I/DandPAI‐1 4G/5Gpolymorphisms on plasma PAI‐1 levelsClinical Genetics, 2002
- Multifactor-Dimensionality Reduction Reveals High-Order Interactions among Estrogen-Metabolism Genes in Sporadic Breast CancerThe American Journal of Human Genetics, 2001
- A Combinatorial Partitioning Method to Identify Multilocus Genotypic Partitions That Predict Quantitative Trait VariationGenome Research, 2001
- Polymorphism of Angiotensin Converting Enzyme Gene Is Associated With Circulating Levels of Plasminogen Activator Inhibitor-1Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
- The renin-angiotensin system and fibrinolysisThe American Journal of Cardiology, 1997
- A Prospective Evaluation of an Angiotensin-Converting–Enzyme Gene Polymorphism and the Risk of Ischemic Heart DiseaseNew England Journal of Medicine, 1995
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989